CD38 antibodies in multiple myeloma: back to the future von van de Donk, Niels W.C.J., Richardson, Paul G., Malavasi, Fabio

Volltext

Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy von Malavasi, Fabio, Faini, Angelo Corso

Volltext

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma von Morandi, Fabio, Horenstein, Alberto L, Costa, Federica, Giuliani, Nicola, Pistoia, Vito, Malavasi, Fabio

Volltext

The Key Role of NAD + in Anti-Tumor Immune Response: An Update von Morandi, Fabio, Horenstein, Alberto Leonardo, Malavasi, Fabio

Volltext

Editorial: CD38 and retinoids: a step toward a cure von Malavasi, Fabio

Volltext

CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy von Horenstein, Alberto L, Bracci, Cristiano, Morandi, Fabio, Malavasi, Fabio

Volltext

CD38 and chronic lymphocytic leukemia: a decade later von Malavasi, Fabio, Deaglio, Silvia, Damle, Rajendra, Cutrona, Giovanna, Ferrarini, Manlio, Chiorazzi, Nicholas

Volltext

Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology von Malavasi, Fabio, Deaglio, Silvia, Funaro, Ada, Ferrero, Enza, Horenstein, Alberto L, Ortolan, Erika, Vaisitti, Tiziana, Aydin, Semra

Volltext

Editorial: Immunotherapy in Multiple Myeloma von Giuliani, Nicola, Malavasi, Fabio

Volltext

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections von Katsuyama, Eri, Suarez-Fueyo, Abel, Bradley, Sean J., Mizui, Masayuki, Marin, Ana V., Mulki, Lama, Krishfield, Suzanne, Malavasi, Fabio, Yoon, Joon, Sui, Shannan J. Ho, Kyttaris, Vasileios C., Tsokos, George C.

Volltext

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma von van de Donk, Niels W.C.J., Moreau, Philippe, Plesner, Torben, Palumbo, Antonio, Gay, Francesca, Laubach, Jacob P., Malavasi, Fabio, Avet-Loiseau, Hervé, Mateos, Maria-Victoria, Sonneveld, Pieter, Lokhorst, Henk M., Richardson, Paul G.

Volltext

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia von Brusa, Davide, Serra, Sara, Coscia, Marta, Rossi, Davide, D'Arena, Giovanni, Laurenti, Luca, Jaksic, Ozren, Fedele, Giorgio, Inghirami, Giorgio, Gaidano, Gianluca, Malavasi, Fabio, Deaglio, Silvia

Volltext

CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer von Karakasheva, Tatiana A, Waldron, Todd J, Eruslanov, Evgeniy, Kim, Sang-Bae, Lee, Ju-Seog, O'Brien, Shaun, Hicks, Philip D, Basu, Devraj, Singhal, Sunil, Malavasi, Fabio, Rustgi, Anil K

Volltext

The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma von Marimpietri, Danilo, Airoldi, Irma, Faini, Angelo Corso, Malavasi, Fabio, Morandi, Fabio

Volltext

Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma von Horenstein, Alberto L, Quarona, Valeria, Toscani, Denise, Costa, Federica, Chillemi, Antonella, Pistoia, Vito, Giuliani, Nicola, Malavasi, Fabio

Volltext

CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology von Engel, Pablo, Boumsell, Laurence, Balderas, Robert, Bensussan, Armand, Gattei, Valter, Horejsi, Vaclav, Jin, Bo-Quan, Malavasi, Fabio, Mortari, Frank, Schwartz-Albiez, Reinhard, Stockinger, Hannes, van Zelm, Menno C, Zola, Heddy, Clark, Georgina

Volltext

Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network von AUDRITO, Valentina, VAISITTI, Tiziana, ROSSI, Davide, GOTTARDI, Daniela, D'ARENA, Giovanni, LAURENTI, Luca, GAIDANO, Gianluca, MALAVASI, Fabio, DEAGLIO, Silvia

Volltext

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis von Palladini, Giovanni, Milani, Paolo, Malavasi, Fabio, Merlini, Giampaolo

Volltext

The Circular Life of Human CD38: From Basic Science to Clinics and Back von Horenstein, Alberto L, Faini, Angelo C, Morandi, Fabio, Bracci, Cristiano, Lanza, Francesco, Giuliani, Nicola, Paulus, Aneel, Malavasi, Fabio

Volltext

CD14+CD16+ monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy von Storti, Paola, Vescovini, Rosanna, Costa, Federica, Marchica, Valentina, Toscani, Denise, Dalla Palma, Benedetta, Craviotto, Luisa, Malavasi, Fabio, Giuliani, Nicola

Volltext